Van Well Daan 4
4 · SOPHiA GENETICS SA · Filed Mar 20, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CLO Daan Van Well Sells 684 Shares
What Happened
Daan Van Well, Chief Legal Officer of SOPHiA GENETICS SA (SOPH), sold 684 shares in an open-market transaction on March 19, 2026. The weighted-average sale price was $4.79 per share, for total proceeds of $3,274. This was a sale (routine liquidity) rather than a purchase.
Key Details
- Transaction date: 2026-03-19 (reported on Form 4 filed 2026-03-20)
- Transaction type/code: Sale (S) — open market
- Shares sold: 684; Weighted-average price: $4.79; Total value: $3,274
- Price range: $4.69 to $4.87 (shares sold in multiple trades; per-footnote the filer can provide per-price breakdown on request)
- Reason/footnote: Sold to satisfy tax obligations related to RSU vesting on 2026-03-18; executed under a pre-established Rule 10b5-1 trading plan (non-discretionary)
- Shares owned after transaction: Not specified in the filing
- Filing timeliness: Filed the day after the transaction; no late filing indicated
Context
This sale was executed to cover tax withholding from restricted stock unit vesting and was made under a 10b5-1 plan, which means it was pre-planned and not an ad-hoc, discretionary trade. Such sell-to-cover transactions are common and generally represent routine tax-related liquidity rather than a direct signal about executive sentiment toward the stock.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-03-19$4.79/sh−684$3,274→ 261,238 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax obligations in connection with the vesting of restricted stock units on March 18, 2026. The sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.69 to $4.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.